These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina. Chaffiol A; Caplette R; Jaillard C; Brazhnikova E; Desrosiers M; Dubus E; Duhamel L; Macé E; Marre O; Benoit P; Hantraye P; Bemelmans AP; Bamberg E; Duebel J; Sahel JA; Picaud S; Dalkara D Mol Ther; 2017 Nov; 25(11):2546-2560. PubMed ID: 28807567 [TBL] [Abstract][Full Text] [Related]
3. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management. Nyns ECA; Kip A; Bart CI; Plomp JJ; Zeppenfeld K; Schalij MJ; de Vries AAF; Pijnappels DA Eur Heart J; 2017 Jul; 38(27):2132-2136. PubMed ID: 28011703 [TBL] [Abstract][Full Text] [Related]
4. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element. Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785 [TBL] [Abstract][Full Text] [Related]
5. Serotype-based evaluation of an optogenetic construct in rat cortical astrocytes. Balachandar L; Borrego D; Diaz JR Biochem Biophys Res Commun; 2022 Feb; 593():35-39. PubMed ID: 35051780 [TBL] [Abstract][Full Text] [Related]
6. Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age. Denegri M; Bongianino R; Lodola F; Boncompagni S; De Giusti VC; Avelino-Cruz JE; Liu N; Persampieri S; Curcio A; Esposito F; Pietrangelo L; Marty I; Villani L; Moyaho A; Baiardi P; Auricchio A; Protasi F; Napolitano C; Priori SG Circulation; 2014 Jun; 129(25):2673-81. PubMed ID: 24888331 [TBL] [Abstract][Full Text] [Related]
7. Non-invasive, Focused Ultrasound-Facilitated Gene Delivery for Optogenetics. Wang S; Kugelman T; Buch A; Herman M; Han Y; Karakatsani ME; Hussaini SA; Duff K; Konofagou EE Sci Rep; 2017 Jan; 7():39955. PubMed ID: 28059117 [TBL] [Abstract][Full Text] [Related]
8. Optical Manipulation of Perfused Mouse Heart Expressing Channelrhodopsin-2 in Rhythm Control. Wang X; Cheng Y Methods Mol Biol; 2021; 2191():377-390. PubMed ID: 32865755 [TBL] [Abstract][Full Text] [Related]
9. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia. Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499 [TBL] [Abstract][Full Text] [Related]
10. Optogenetic termination of atrial fibrillation in mice. Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898 [TBL] [Abstract][Full Text] [Related]
11. Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model. Nyns ECA; Jin T; Fontes MS; van den Heuvel T; Portero V; Ramsey C; Bart CI; Zeppenfeld K; Schalij MJ; van Brakel TJ; Ramkisoensing AA; Zhang G; Poelma RH; Ördög B; de Vries AAF; Pijnappels DA Cardiovasc Res; 2022 Jul; 118(10):2293-2303. PubMed ID: 34528100 [TBL] [Abstract][Full Text] [Related]
12. Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina. Ameline B; Tshilenge KT; Weber M; Biget M; Libeau L; Caplette R; Mendes-Madeira A; Provost N; Guihal C; Picaud S; Moullier P; Pichard V; Cronin T; Isiegas C Gene Ther; 2017 Nov; 24(11):735-741. PubMed ID: 28880021 [TBL] [Abstract][Full Text] [Related]
13. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions. Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741 [TBL] [Abstract][Full Text] [Related]
14. Optogenetic Modulation for the Treatment of Traumatic Brain Injury. Delaney SL; Gendreau JL; D'Souza M; Feng AY; Ho AL Stem Cells Dev; 2020 Feb; 29(4):187-197. PubMed ID: 31559914 [TBL] [Abstract][Full Text] [Related]
15. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models. Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078 [TBL] [Abstract][Full Text] [Related]
16. Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Lipshutz GS; Titre D; Brindle M; Bisconte AR; Contag CH; Gaensler KM Mol Ther; 2003 Jul; 8(1):90-8. PubMed ID: 12842432 [TBL] [Abstract][Full Text] [Related]